Vygon GmbH & Co. KG
6
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
The PIV5Rights Safety and Quality Bundle
Role: collaborator
Efficacy of Sternum Guard in Post Cardiac Surgery Patient
Role: collaborator
Comparison of Haemodynamic Effects During Orotracheal Intubation, by Direct or Indirect Laryngoscopy With Airtraq
Role: collaborator
Prospective Analysis of Incidence and Risk Factors of Infection of Midline Catheter
Role: collaborator
Influence of Bionecteurs on Catheter-associated Infection
Role: collaborator
Prospective Trial of the Bilevel Positive Airway Pressure (by Boussignac) in Emergency Department of Non-invasive Patients Presenting With Acute Hypercapnic Respiratory Failure
Role: lead
All 6 trials loaded